Amnioinfusion for third trimester preterm premature rupture of membranes Guideline WHO recommendations: non-clinical interventions to reduce unnecessary caesarean sections Caesarean section rates have been steadily increasing worldwide over the last few decades above levels that cannot be considered medically necessary. This trend has not been accompanied by significant maternal or perinatal benefits. In recognition of the urgent need to address this sustained and unprecedented rise in the use of caesarean section, WHO has produced evidence-based guidance on non-clinical interventions specifically designed to reduce unnecessary caesarean section. These recommendations can be useful to health-care professionals responsible for developing regional, national and local health protocols and policies, as well as obstetricians, midwives, nurses, general medical practitioners, managers of maternal and child health programmes, and public health policy-makers in all settings and countries where increasing use of caesarean section has been identified as a problem.
|Published (Last):||3 July 2017|
|PDF File Size:||19.3 Mb|
|ePub File Size:||19.54 Mb|
|Price:||Free* [*Free Regsitration Required]|
Las diferentes dosis de heparina utilizadas en los estudios revisados no alteraron los resultados. Por otra parte, la inmunoglobina intravenosa IgIV y la prednisona no mostraron beneficios sino efectos adversos. Las embarazadas con bajo nivel de anticuerpos ACL o LA positivos pueden correr un menor riesgo de obtener resultados adversos. Acta Medicine Scandinavia ;— Antiphospholipid antibodies in predicting adverse pregnancy outcome.
A prospective study. Annals of Internal Medicine ;— Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstetrics and Gynecology ;— Pregnancy loss in the antiphospholipid-antibody syndrome — a possible thrombogenic mechanism. New England Journal of Medicine ;— Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies.
Fertility and Sterility ;— Association of antibodies to beta2-glycoprotein 1 with pregnancy loss and pregnancy-induced hypertension: a prospective study in low-risk pregnancy. Velayuthaprabhu S, Archunan G. Evaluation of anticardiolipin antibodies and antiphosphatidylserine antibodies in women with recurrent abortion. Indian Journal of Medical Sciences ;—